Global Left Ventricular Assist Device (LVAD) Market Growth 2023-2029

Global Left Ventricular Assist Device (LVAD) Market Growth 2023-2029

A left ventricular assist device (LVAD) is a pump that we use for patients who have reached end-stage heart failure.
LPI (LP Information)' newest research report, the “Left Ventricular Assist Device (LVAD) Industry Forecast” looks at past sales and reviews total world Left Ventricular Assist Device (LVAD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Left Ventricular Assist Device (LVAD) sales for 2023 through 2029. With Left Ventricular Assist Device (LVAD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Left Ventricular Assist Device (LVAD) industry.
This Insight Report provides a comprehensive analysis of the global Left Ventricular Assist Device (LVAD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Left Ventricular Assist Device (LVAD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Left Ventricular Assist Device (LVAD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Left Ventricular Assist Device (LVAD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Left Ventricular Assist Device (LVAD).
The global Left Ventricular Assist Device (LVAD) market size is projected to grow from US$ 2389.1 million in 2022 to US$ 6658.1 million in 2029; it is expected to grow at a CAGR of 6658.1 from 2023 to 2029.
AbioMed, Abbott (Thoratec), Medtronic (HeartWare), Berlin Heart, etc. are the leaders of the industry, with high-end customers.
This report presents a comprehensive overview, market shares, and growth opportunities of Left Ventricular Assist Device (LVAD) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
BTT Therapy
Destination Therapy (DT)
Other
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart
Jarvik Heart
Sun Medical Technology Research
ReliantHeart
Market Segment by Product Type
BTT Therapy
Destination Therapy (DT)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Left Ventricular Assist Device (LVAD) market?
What factors are driving Left Ventricular Assist Device (LVAD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Left Ventricular Assist Device (LVAD) market opportunities vary by end market size?
How does Left Ventricular Assist Device (LVAD) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.